✦ LIBER ✦

Prospective Randomized Controlled Trial of Extended-Release Oxybutynin Chloride and Tolterodine Tartrate in the Treatment of Overactive Bladder: Results of the OBJECT Study

✍ Scribed by Appell, Rodney A.; Sand, Peter; Dmochowski, Roger; Anderson, Rodney; Zinner, Norman; Lama, Daniel; Roach, Martha; Miklos, John; Saltzstein, Daniel; Boone, Timothy

Book ID: 123236767
Publisher: Mayo Clinic
Year: 2001
Tongue: English
Weight: 64 KB
Volume: 76
Category: Article
ISSN: 0025-6196
DOI: 10.4065/76.4.358

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective, Randomized, Double-Blind St

Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial

✍ Diokno, Ananias C.; Appell, Rodney A.; Sand, Peter K.; Dmochowski, Roger R.; Gbu 📂 Article 📅 2003 🏛 Mayo Clinic 🌐 English ⚖ 93 KB

Canadian economic comparison of extended

Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder

✍ Denis Getsios; J.Jaime Caro; K.Jack Ishak; Wissam El-Hadi; Krista Payne 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Randomized Trial of Percutaneous Tibial

Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy Trial

✍ Peters, Kenneth M.; MacDiarmid, Scott A.; Wooldridge, Leslie S.; Leong, Fah Che; 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 366 KB

Cost Effectiveness of Controlled-Release

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

✍ Dr Julian F. Guest, Dele Abegunde, Francis J. Ruiz 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 148 KB

Comparison of fesoterodine and tolterodi

Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial

✍ Sender Herschorn; Steven Swift; Zhonghong Guan; Martin Carlsson; Jon D. Morrow; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

740 A randomised controlled trial of fes

740 A randomised controlled trial of fesoterodine in subjects with overactive bladder and suboptimal response to tolterodine extended release: Results from the AFTER study

✍ Cardozo, L.; Kaplan, S.; Herschorn, S.; Grenabo, L.; Carlsson, M.; Arumi, D.; Cr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 101 KB